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Introduction
Allergic rhinitis is a symptomatic disorder whosemain effect
occurs on the nasal mucosa. This effect is induced by expo-
sure to allergens, which trigger an inflammatory process
mediated by immunoglobulin-E (Ig-E).1 This condition is
relatively frequent and has a high prevalence between 13
and 14 years of age, a group in which it can reach 14.6%.
According to the data reported by the International Study of
Asthma and Allergies in Childhood (ISAAC).2 From a global
perspective, Africa and Latin America have the highest
reported prevalence (18% and 17.3% respectively), and
Colombia ranks 5th worldwide, reaching a percentage of
25.2% of cases in the adolescent population.2 Due to the high
burden of the disease, the volume of consultations generated
by this condition is understandable, with examples such as










Abstract Introduction Oral antihistamines and intranasal corticosteroids have been shown to
be effective and safe for the treatment of allergic rhinitis; however, the evidence
suggests a level of superiority of corticosteroids, so they should be preferred over the
former.
Objective To know the prescription profile of two second generation antihistamines
(cetirizine and levocetirizine) and two nasal corticosteroids (mometasone and furoate-
ciclesonide) in a cohort of patients with allergic rhinitis, and to compare the clinical
outcomes obtained.
Methods A cohort study was carried including patients with allergic rhinitis treated
with cetirizine, levocetirizine, mometasone furoate or ciclesonide. The improvement
was evaluated with the total nasal symptoms score (TNSS). This scale yields results
between 0 and 12. Zero indicates absence of symptoms.
Results A total of 314 patients completed 12weeks of follow-up. Seventy-five percent
were treated with antihistamines, 20% with corticosteroids, and 5% with a combination
of the above. The TNSS median for corticosteroid was 2.5 points; for antihistamines, its
was 5 points, and for combination, it was 4 points. We found differences between
corticosteroids and antihistamines.
Conclusion The prescription percentage of second generation oral antihistamines is
higher than that of intranasal corticosteroids. However, patients with allergic rhinitis
treated with the second option obtained better control of symptoms.
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